Go Pro

Planet Labs PBC (PL) Financials

Planet Labs PBC logo
$17.40 -0.22 (-1.23%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$17.45 +0.05 (+0.29%)
As of 09/25/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Planet Labs PBC

Annual Income Statements for Planet Labs PBC

This table shows Planet Labs PBC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-124 -127 -137 -162 -141 -123 -247
Consolidated Net Income / (Loss)
-124 -127 -137 -162 -141 -123 -247
Net Income / (Loss) Continuing Operations
-124 -127 -137 -162 -141 -123 -247
Total Pre-Tax Income
-124 -126 -135 -161 -140 -121 -242
Total Operating Income
-106 -87 -128 -176 -170 -116 -95
Total Gross Profit
-6.66 26 48 94 113 140 172
Total Revenue
96 113 131 191 221 244 308
Operating Revenue
96 113 131 191 221 244 308
Total Cost of Revenue
102 87 83 97 108 105 135
Operating Cost of Revenue
102 87 83 97 108 105 135
Total Operating Expenses
100 113 176 270 283 256 268
Selling, General & Admin Expense
27 32 57 81 80 77 88
Marketing Expense
35 37 53 78 86 78 73
Research & Development Expense
38 44 67 111 116 101 107
Total Other Income / (Expense), net
-17 -39 -6.96 15 30 -4.61 -147
Interest Expense
18 8.77 10 - 0.00 0.83 3.44
Interest & Investment Income
- 0.05 0.02 7.67 15 10 14
Other Income / (Expense), net
1.35 -30 3.48 6.88 15 -14 -158
Income Tax Expense
0.13 1.07 2.11 0.85 0.82 2.46 4.66
Basic Earnings per Share
($2.89) ($2.87) ($1.72) ($0.61) ($0.50) ($0.42) ($0.80)
Weighted Average Basic Shares Outstanding
42.86M 44.21M 79.61M 267.13M 279.59M 292.12M 307.80M
Diluted Earnings per Share
($2.89) ($2.87) ($1.72) ($0.61) ($0.50) ($0.42) ($0.80)
Weighted Average Diluted Shares Outstanding
42.86M 44.21M 79.61M 267.13M 279.59M 292.12M 307.80M
Weighted Average Basic & Diluted Shares Outstanding
- - 267.90M 274.97M 290.62M 302.25M 346.15M

Quarterly Income Statements for Planet Labs PBC

This table shows Planet Labs PBC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-30 -29 -39 -20 -35 -13 -23 -59 -152 -139 -9.35
Consolidated Net Income / (Loss)
-30 -29 -39 -20 -35 -13 -23 -59 -152 -139 -9.35
Net Income / (Loss) Continuing Operations
-30 -29 -39 -20 -35 -13 -23 -59 -152 -139 -9.35
Total Pre-Tax Income
-31 -29 -38 -20 -34 -12 -22 -58 -150 -138 -8.62
Total Operating Income
-34 -35 -40 -23 -19 -23 -18 -18 -36 -35 -14
Total Gross Profit
32 32 32 38 38 37 42 47 47 50 66
Total Revenue
59 60 61 61 62 66 73 81 87 94 116
Operating Revenue
59 60 61 61 62 66 73 81 87 94 116
Total Cost of Revenue
26 29 29 24 23 30 31 35 40 44 50
Operating Cost of Revenue
26 29 29 24 23 30 31 35 40 44 50
Total Operating Expenses
66 66 72 60 58 59 60 65 83 85 79
Selling, General & Admin Expense
18 19 21 18 19 20 18 19 31 29 22
Marketing Expense
20 21 24 17 16 16 18 19 20 23 21
Research & Development Expense
28 26 27 25 23 23 24 27 32 33 35
Total Other Income / (Expense), net
3.40 5.72 1.81 2.55 -15 11 -4.14 -40 -114 -103 4.89
Interest Expense
- - - 0.28 - 0.50 0.32 1.02 - 1.45 1.44
Interest & Investment Income
3.66 3.11 2.77 2.41 1.97 1.88 2.17 4.41 5.86 5.15 6.43
Other Income / (Expense), net
-0.26 2.61 -0.97 0.42 -17 9.69 -5.99 -43 -117 -107 -0.11
Income Tax Expense
-0.43 0.44 0.90 0.03 1.12 0.93 0.50 0.78 2.45 1.01 0.73
Basic Earnings per Share
($0.10) ($0.10) ($0.13) ($0.07) ($0.12) ($0.04) ($0.07) ($0.19) ($0.50) ($0.40) ($0.03)
Weighted Average Basic Shares Outstanding
279.59M 288.27M 290.36M 293.34M 292.12M 300.27M 304.13M 309.25M 307.80M 345.52M 359.59M
Diluted Earnings per Share
($0.10) ($0.10) ($0.13) ($0.07) ($0.12) ($0.04) ($0.07) ($0.19) ($0.50) ($0.40) ($0.03)
Weighted Average Diluted Shares Outstanding
279.59M 288.27M 290.36M 293.34M 292.12M 300.27M 304.13M 309.25M 307.80M 345.52M 359.59M
Weighted Average Basic & Diluted Shares Outstanding
290.62M 290.77M 293.48M 296.71M 302.25M 303.43M 307.92M 313.66M 346.15M 356.40M 363.85M

Annual Cash Flow Statements for Planet Labs PBC

This table details how cash moves in and out of Planet Labs PBC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents
-52 49 420 -309 -86 28 106
Net Cash From Operating Activities
-34 -4.03 -42 -74 -51 -14 134
Net Cash From Continuing Operating Activities
-34 -4.03 -42 -74 -51 -14 134
Net Income / (Loss) Continuing Operations
-124 -127 -137 -162 -141 -123 -247
Consolidated Net Income / (Loss)
-124 -127 -137 -162 -141 -123 -247
Depreciation Expense
78 62 45 43 48 46 42
Non-Cash Adjustments To Reconcile Net Income
17 43 39 69 43 64 216
Changes in Operating Assets and Liabilities, net
-6.04 15 8.19 -24 -1.26 -0.42 123
Net Cash From Investing Activities
-27 -31 -25 -242 -34 58 -393
Net Cash From Continuing Investing Activities
-27 -31 -25 -242 -34 58 -393
Purchase of Property, Plant & Equipment
-24 -30 -15 -13 -42 -50 -81
Acquisitions
-2.46 0.00 -9.62 -3.82 -7.54 -5.85 -6.85
Purchase of Investments
- 0.00 0.00 -280 -189 -140 -428
Sale and/or Maturity of Investments
- 0.00 0.00 55 207 254 123
Other Investing Activities, net
-0.61 -0.67 -0.60 -0.56 -1.39 -0.30 0.00
Net Cash From Financing Activities
8.73 84 489 7.86 -1.60 -16 357
Net Cash From Continuing Financing Activities
8.73 84 489 7.86 -1.60 -16 357
Repayment of Debt
-51 -2.59 -67 -0.50 -0.02 -0.74 -5.73
Issuance of Debt
50 86 - - 0.00 0.00 449
Issuance of Common Equity
- - - 0.00 0.00 1.55 2.80
Other Financing Activities, net
0.26 0.54 556 8.36 -1.58 -16 -89
Effect of Exchange Rate Changes
- -0.31 -1.55 -0.40 0.02 -0.20 7.26

Quarterly Cash Flow Statements for Planet Labs PBC

This table details how cash moves in and out of Planet Labs PBC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Change in Cash & Equivalents
-18 24 41 -17 -20 16 47 257 -214 140 48
Net Cash From Operating Activities
-6.84 -4.30 -7.86 4.08 -6.30 17 68 29 21 15 53
Net Cash From Continuing Operating Activities
-6.84 -4.30 -7.86 4.08 -6.30 17 68 29 21 15 53
Net Income / (Loss) Continuing Operations
-30 -29 -39 -20 -35 -13 -23 -59 -152 -139 -9.35
Consolidated Net Income / (Loss)
-30 -29 -39 -20 -35 -13 -23 -59 -152 -139 -9.35
Depreciation Expense
12 13 13 10 9.27 11 11 9.91 10 11 11
Non-Cash Adjustments To Reconcile Net Income
13 12 12 12 28 2.16 19 57 138 123 17
Changes in Operating Assets and Liabilities, net
-1.17 0.35 5.50 2.41 -8.67 17 61 21 25 20 34
Net Cash From Investing Activities
-9.55 30 51 -11 -13 1.74 -19 -171 -204 30 -117
Net Cash From Continuing Investing Activities
-9.55 30 51 -11 -13 1.74 -19 -171 -204 30 -117
Purchase of Property, Plant & Equipment
-10 -11 -17 -8.86 -13 -9.34 -21 -28 -23 -18 -29
Acquisitions
- -5.09 -0.27 -0.27 -0.23 -0.62 -0.27 -0.26 -5.70 -0.27 -0.26
Purchase of Investments
-23 -28 -54 -24 -35 0.00 -22 -185 -221 -33 -175
Sale and/or Maturity of Investments
24 75 122 22 35 12 25 42 45 82 87
Other Investing Activities, net
-0.45 -0.30 - - - 0.00 - - - 0.00 -0.35
Net Cash From Financing Activities
-1.24 -2.38 -2.73 -10 -0.23 -9.16 -1.00 398 -31 95 114
Net Cash From Continuing Financing Activities
-1.24 -2.38 -2.73 -10 -0.23 -9.16 -1.00 398 -31 95 114
Issuance of Common Equity
- 0.00 - 0.38 0.47 0.35 0.82 0.69 0.95 1.33 124
Other Financing Activities, net
-1.24 -2.00 -3.47 -10 -0.57 -7.12 -1.68 -48 -32 94 -7.86
Effect of Exchange Rate Changes
0.08 -0.28 0.24 0.11 -0.28 5.68 -0.01 0.85 0.73 -1.02 -1.30

Annual Balance Sheets for Planet Labs PBC

This table presents Planet Labs PBC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets
0.09 399 821 753 702 634 1,146
Total Current Assets
0.00 125 552 476 370 302 775
Cash & Equivalents
0.00 71 491 182 84 118 229
Restricted Cash
- - - 0.53 8.36 6.60 0.64
Short-Term Investments
- - 0.00 227 215 104 411
Accounts Receivable
- 47 44 39 43 56 84
Inventories, net
- - - - - 0.00 6.12
Prepaid Expenses
0.00 7.13 16 27 20 18 45
Plant, Property, & Equipment, net
0.00 160 133 108 113 122 151
Total Noncurrent Assets
0.09 114 137 169 218 210 220
Goodwill
- 88 103 113 136 136 143
Intangible Assets
- 18 25 26 47 46 48
Other Noncurrent Operating Assets
0.09 7.97 8.46 30 25 22 23
Other Noncurrent Nonoperating Assets
- - - - 9.97 5.35 5.47
Total Liabilities & Shareholders' Equity
0.09 399 821 753 702 634 1,146
Total Liabilities
0.06 292 173 177 184 193 957
Total Current Liabilities
0.06 109 132 122 137 142 469
Accounts Payable
0.01 1.45 2.85 6.90 2.60 2.60 11
Accrued Expenses
0.05 30 49 46 45 43 56
Current Deferred Revenue
- 58 64 52 72 82 221
Other Current Liabilities
- 11 16 17 17 15 182
Total Noncurrent Liabilities
0.00 183 41 54 47 50 488
Long-Term Debt
- 156 - - - 0.00 447
Noncurrent Deferred Revenue
- 18 4.38 2.88 5.29 11 28
Other Noncurrent Operating Liabilities
0.00 9.26 37 51 42 39 13
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.02 108 648 576 518 441 188
Total Preferred & Common Equity
0.02 108 648 576 518 441 188
Total Common Equity
0.02 107 648 576 518 441 188
Common Stock
0.03 746 1,423 1,513 1,596 1,645 1,632
Retained Earnings
-0.00 -640 -777 -939 -1,080 -1,203 -1,450
Accumulated Other Comprehensive Income / (Loss)
- 1.77 2.10 2.27 1.59 -1.10 6.36

Quarterly Balance Sheets for Planet Labs PBC

This table presents Planet Labs PBC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025 4/30/2026 7/31/2026
Total Assets
723 720 714 675 658 631 658 696 1,106 1,251 1,431
Total Current Assets
435 428 388 346 327 302 325 355 754 849 999
Cash & Equivalents
141 119 102 107 148 139 133 181 443 368 415
Restricted Cash
- - 7.88 8.80 8.80 6.53 6.61 6.32 0.91 0.90 1.89
Short-Term Investments
235 249 213 168 101 103 93 90 234 363 450
Accounts Receivable
39 40 45 39 44 39 75 52 46 62 60
Inventories, net
- - - - - - - - - 9.34 8.85
Prepaid Expenses
19 20 20 23 25 14 17 26 30 46 63
Plant, Property, & Equipment, net
118 120 114 111 113 117 122 131 145 159 176
Total Noncurrent Assets
171 172 212 217 218 212 211 210 207 243 256
Goodwill
113 113 136 137 137 137 138 139 139 143 143
Intangible Assets
26 28 41 47 48 47 48 47 47 46 50
Other Noncurrent Operating Assets
26 26 24 23 24 23 20 18 16 47 56
Other Noncurrent Nonoperating Assets
5.66 5.71 10 9.56 9.54 4.44 5.53 5.53 5.37 6.61 6.61
Total Liabilities & Shareholders' Equity
723 720 714 675 658 631 658 696 1,106 1,251 1,431
Total Liabilities
164 181 180 174 185 166 214 261 757 808 867
Total Current Liabilities
112 116 131 126 140 129 155 203 189 303 351
Accounts Payable
15 3.83 4.59 3.13 2.39 3.57 4.10 11 3.45 9.04 10
Accrued Expenses
34 38 42 43 57 44 29 32 29 59 56
Current Deferred Revenue
45 57 67 64 65 66 108 148 146 231 281
Other Current Liabilities
18 18 17 16 16 15 13 12 11 4.29 3.62
Total Noncurrent Liabilities
52 65 49 48 45 37 59 57 568 505 515
Long-Term Debt
- - - - - - - - 446 448 448
Noncurrent Deferred Revenue
2.47 18 7.76 13 12 11 30 25 48 16 17
Other Noncurrent Operating Liabilities
50 46 41 35 33 26 29 32 73 41 50
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
559 540 534 500 473 465 445 436 350 444 564
Total Preferred & Common Equity
559 540 534 500 473 465 445 436 350 444 564
Total Common Equity
559 540 534 500 473 465 445 436 350 444 564
Common Stock
1,531 1,550 1,584 1,609 1,620 1,631 1,657 1,670 1,643 2,028 2,159
Retained Earnings
-974 -1,012 -1,050 -1,109 -1,148 -1,168 -1,216 -1,238 -1,297 -1,589 -1,598
Accumulated Other Comprehensive Income / (Loss)
1.68 1.34 -0.24 0.55 1.25 1.35 3.69 3.85 4.46 4.92 3.37

Annual Metrics And Ratios for Planet Labs PBC

This table displays calculated financial ratios and metrics derived from Planet Labs PBC's official financial filings.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding
- - - - - - 313,664,721.00
DEI Adjusted Shares Outstanding
- - - - - - 313,664,721.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - -0.79
Growth Metrics
- - - - - - -
Profitability Metrics
- - - - - - -
Net Operating Profit after Tax (NOPAT)
-75 -61 -90 -123 -119 -81 -67
Return On Investment Capital (ROIC_SIMPLE)
- - - -21.35% -22.94% -18.42% -10.48%
Earnings before Interest and Taxes (EBIT)
-105 -117 -125 -169 -155 -131 -253
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-26 -52 -77 -125 -107 -85 -211
Valuation Ratios
- - - - - - -
Leverage & Solvency
- - - - - - -
Liquidity Ratios
- - - - - - -
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -261 -47 -132 -153 -88 152
Efficiency Ratios
- - - - - - -
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.02 200 157 167 201 207 -11
Increase / (Decrease) in Invested Capital
0.00 200 -43 9.33 34 6.49 -218
Book Value per Share
$0.00 $2.43 $15.03 $2.12 $1.80 $1.49 $0.60
Tangible Book Value per Share
$0.00 $0.03 $12.06 $1.61 $1.16 $0.87 ($0.01)
Total Capital
0.02 271 648 576 518 441 635
Total Debt
0.00 164 0.00 0.00 0.00 0.00 447
Total Long-Term Debt
0.00 156 0.00 0.00 0.00 0.00 447
Net Debt
0.00 93 -491 -409 -307 -229 -194
Capital Expenditures (CapEx)
24 30 15 13 42 50 81
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.06 -46 -71 -56 -74 -69 -335
Debt-free Net Working Capital (DFNWC)
-0.06 25 419 353 234 160 306
Net Working Capital (NWC)
-0.06 17 419 353 234 160 306
Net Nonoperating Expense (NNE)
49 66 47 39 22 42 180
Net Nonoperating Obligations (NNO)
0.00 93 -491 -409 -317 -234 -199
Total Depreciation and Amortization (D&A)
79 65 48 43 48 46 42
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.72) ($0.61) ($0.50) ($0.42) ($0.80)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 79.61M 267.13M 279.59M 292.12M 307.80M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.72) ($0.61) ($0.50) ($0.42) ($0.80)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 79.61M 267.13M 279.59M 292.12M 307.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 267.90M 274.97M 290.62M 302.25M 346.15M
Normalized Net Operating Profit after Tax (NOPAT)
-75 -61 -90 -123 -119 -81 -67
Debt Service Ratios
- - - - - - -
Payout Ratios
- - - - - - -

Quarterly Metrics And Ratios for Planet Labs PBC

This table displays calculated financial ratios and metrics derived from Planet Labs PBC's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
DEI Shares Outstanding
- - - - - - - - 313,664,721.00 346,149,027.00 356,402,526.00
DEI Adjusted Shares Outstanding
- - - - - - - - 313,664,721.00 346,149,027.00 356,402,526.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - -0.49 -0.40 -0.03
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.09% 14.68% 13.64% 10.63% 4.59% 9.64% 20.12% 32.62% - 42.08% 58.14%
EBITDA Growth
29.39% 33.60% 5.64% 55.03% -18.52% 86.73% 50.20% -329.67% - -6,409.19% 78.80%
EBIT Growth
17.24% 17.30% 1.59% 45.32% -5.40% 57.49% 40.14% -178.44% - -981.91% 43.16%
NOPAT Growth
20.55% 22.65% 8.56% 52.76% 42.90% 34.13% 54.62% 18.88% - -53.21% 24.78%
Net Income Growth
20.49% 14.95% -1.82% 47.16% -16.85% 56.89% 41.57% -194.73% - -999.71% 58.60%
EPS Growth
28.57% 23.08% 7.14% 46.15% -20.00% 60.00% 46.15% -171.43% - -900.00% 57.14%
Operating Cash Flow Growth
53.85% 85.96% -181.88% 117.82% 7.93% 503.68% 962.48% 601.50% - -10.99% -21.88%
Free Cash Flow Firm Growth
-47.14% 15.21% -66.13% 58.94% 65.27% 69.58% 160.52% 423.16% - 281.05% -89.76%
Invested Capital Growth
20.36% 16.26% 23.75% 5.44% 3.23% 0.10% -25.89% -46.95% - -25.97% -8.94%
Revenue Q/Q Growth
6.27% 2.70% 1.08% 0.28% 0.47% 7.65% 10.75% 10.72% - 8.44% 23.26%
EBITDA Q/Q Growth
17.83% 16.46% -45.30% 54.91% -116.55% 90.65% -445.36% -280.26% - 8.98% 97.83%
EBIT Q/Q Growth
16.83% 6.49% -26.86% 44.58% -60.32% 62.29% -78.64% -154.65% - 7.74% 90.38%
NOPAT Q/Q Growth
29.13% -1.93% -14.48% 42.88% 14.34% -17.58% 21.13% -2.12% - 3.09% 61.28%
Net Income Q/Q Growth
20.83% 2.64% -32.00% 48.07% -75.06% 64.08% -78.90% -161.97% - 8.91% 93.27%
EPS Q/Q Growth
23.08% 0.00% -30.00% 46.15% -71.43% 66.67% -75.00% -171.43% - 20.00% 92.50%
Operating Cash Flow Q/Q Growth
70.10% 37.15% -82.87% 151.87% -254.44% 375.55% 290.72% -57.81% - -25.23% 242.93%
Free Cash Flow Firm Q/Q Growth
11.39% 8.04% -26.54% 60.17% 25.05% 19.47% 351.77% 112.67% - -84.86% -85.75%
Invested Capital Q/Q Growth
0.14% 2.79% -0.42% 2.87% -1.96% -0.33% -26.27% -26.36% - 1,504.59% -9.31%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
55.19% 52.42% 52.89% 61.24% 62.08% 55.24% 57.60% 57.33% - 53.53% 56.55%
EBITDA Margin
-38.35% -31.20% -44.85% -20.16% -43.46% -3.78% -18.59% -63.86% - -138.48% -2.44%
Operating Margin
-57.63% -57.20% -64.78% -36.90% -31.46% -34.36% -24.47% -22.57% - -37.06% -11.64%
EBIT Margin
-58.07% -52.88% -66.36% -36.68% -58.52% -20.50% -33.07% -76.05% - -150.36% -11.73%
Profit (Net Income) Margin
-51.12% -48.47% -63.29% -32.78% -57.11% -19.06% -30.79% -72.84% - -147.50% -8.06%
Tax Burden Percent
98.59% 101.53% 102.37% 100.12% 103.22% 107.93% 102.25% 101.34% - 100.73% 108.50%
Interest Burden Percent
89.29% 90.28% 93.17% 89.26% 94.55% 86.13% 91.05% 94.51% - 97.38% 63.32%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Invested Capital (ROIC)
-48.44% -47.65% -57.54% -30.31% -26.38% -29.15% -25.13% -27.58% - -48.43% -21.18%
ROIC Less NNEP Spread (ROIC-NNEP)
-46.70% -46.14% -54.12% -28.86% -18.54% -30.39% -21.50% -8.69% - -5.16% -21.21%
Return on Net Nonoperating Assets (RNNOA)
31.01% 29.43% 34.27% 16.95% 10.65% 17.11% 13.03% 5.24% - 3.07% 15.04%
Return on Equity (ROE)
-17.43% -18.22% -23.28% -13.36% -15.72% -12.03% -12.10% -22.35% - -45.36% -6.14%
Cash Return on Invested Capital (CROIC)
-83.13% -73.25% -79.97% -49.71% -43.02% -35.46% -2.62% 27.41% - -11.90% -40.07%
Operating Return on Assets (OROA)
-17.62% -17.28% -22.70% -13.19% -21.41% -7.69% -12.81% -24.74% - -52.85% -4.17%
Return on Assets (ROA)
-15.51% -15.84% -21.65% -11.78% -20.89% -7.15% -11.93% -23.69% - -51.84% -2.87%
Return on Common Equity (ROCE)
-17.43% -18.22% -23.28% -13.36% -15.72% -12.03% -12.10% -22.35% - -45.36% -6.14%
Return on Equity Simple (ROE_SIMPLE)
0.00% -27.05% -28.75% -25.43% 0.00% -23.95% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-24 -24 -28 -16 -14 -16 -13 -13 -25 -24 -9.46
NOPAT Margin
-40.34% -40.04% -45.35% -25.83% -22.02% -24.05% -17.13% -15.80% - -25.94% -8.15%
Net Nonoperating Expense Percent (NNEP)
-1.75% -1.51% -3.42% -1.45% -7.84% 1.24% -3.64% -18.89% - -43.27% 0.03%
Return On Investment Capital (ROIC_SIMPLE)
-4.58% -4.84% - - -3.07% -3.58% -2.89% -1.61% -3.97% -2.74% -0.93%
Cost of Revenue to Revenue
44.81% 47.58% 47.11% 38.76% 37.92% 44.76% 42.40% 42.67% - 46.47% 43.45%
SG&A Expenses to Revenue
30.41% 31.73% 34.22% 29.57% 30.78% 30.16% 25.21% 23.15% - 30.89% 19.38%
R&D to Revenue
48.27% 42.34% 44.60% 41.16% 37.29% 34.82% 32.92% 33.63% - 35.50% 30.29%
Operating Expenses to Revenue
112.82% 109.62% 117.67% 98.14% 93.55% 89.60% 82.07% 79.90% - 90.59% 68.19%
Earnings before Interest and Taxes (EBIT)
-34 -32 -41 -22 -36 -14 -24 -62 -153 -142 -14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-23 -19 -27 -12 -27 -2.50 -14 -52 -143 -130 -2.83
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.25 0.98 1.56 1.40 4.10 2.24 4.35 11.85 - 28.84 12.93
Price to Tangible Book Value (P/TBV)
1.94 1.56 2.56 2.32 7.00 3.84 7.59 25.25 - 50.29 19.67
Price to Revenue (P/Rev)
2.95 2.15 3.13 2.68 7.41 3.97 7.23 14.66 - 38.13 19.30
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.71 1.00 2.34 1.89 7.63 3.69 10.63 34.86 - 81.82 49.61
Enterprise Value to Revenue (EV/Rev)
1.55 0.91 2.04 1.65 6.47 3.04 6.17 13.84 - 37.28 18.19
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 104.79 19.52 36.40 - 94.47 58.49
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.15 - 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.28 - 1.01 0.79
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.28 - 1.01 0.79
Financial Leverage
-0.66 -0.64 -0.63 -0.59 -0.57 -0.56 -0.61 -0.60 - -0.60 -0.71
Leverage Ratio
1.33 1.32 1.36 1.35 1.39 1.41 1.49 2.13 - 2.15 2.13
Compound Leverage Factor
1.19 1.19 1.27 1.20 1.32 1.21 1.36 2.02 - 2.09 1.35
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 56.07% - 50.22% 44.27%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 56.07% - 50.22% 44.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 43.93% - 49.78% 55.73%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.69 - -1.32 -1.36
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.44 - 0.84 1.27
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4.69 - -1.32 -1.36
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -8.13 - -5.97 -6.23
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.23 - 3.79 5.83
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -8.13 - -5.97 -6.23
Altman Z-Score
0.52 -0.04 0.45 0.34 3.48 0.83 2.40 2.33 - 8.15 4.27
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.71 2.74 2.34 2.34 2.13 2.10 1.75 4.00 - 2.81 2.84
Quick Ratio
2.50 2.49 2.10 2.18 1.96 1.95 1.59 3.84 - 2.62 2.63
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-58 -53 -67 -27 -20 -16 41 86 193 29 4.16
Operating Cash Flow to CapEx
-67.98% -37.84% -47.28% 45.99% -49.26% 185.64% 315.43% 103.29% - 85.98% 181.74%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 84.72 - 20.21 2.89
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 28.03 - 10.68 36.80
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.89 - -1.74 16.55
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.30 0.33 0.34 0.36 0.37 0.38 0.39 0.33 - 0.35 0.36
Accounts Receivable Turnover
5.37 5.89 5.60 5.75 4.93 4.42 5.49 6.63 - 4.93 6.79
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Fixed Asset Turnover
1.99 1.99 2.02 2.09 2.08 2.14 2.15 2.16 - 2.38 2.46
Accounts Payable Turnover
22.68 12.59 36.44 26.38 40.20 29.20 16.05 33.84 - 22.73 15.75
Days Sales Outstanding (DSO)
68.03 62.00 65.24 63.44 74.05 82.57 66.44 55.04 - 74.10 53.79
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Payable Outstanding (DPO)
16.09 29.00 10.02 13.83 9.08 12.50 22.75 10.79 - 16.06 23.17
Cash Conversion Cycle (CCC)
51.94 33.00 55.22 49.60 64.98 70.07 43.70 44.25 - 58.05 30.63
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
201 206 206 211 207 207 152 112 -11 153 139
Invested Capital Turnover
1.20 1.19 1.27 1.17 1.20 1.21 1.47 1.75 - 1.87 2.60
Increase / (Decrease) in Invested Capital
34 29 39 11 6.49 0.20 -53 -99 -218 -54 -14
Enterprise Value (EV)
343 207 480 400 1,581 762 1,619 3,910 - 12,513 6,880
Market Capitalization
650 491 739 649 1,810 994 1,896 4,142 - 12,797 7,299
Book Value per Share
$1.80 $1.72 $1.63 $1.58 $1.49 $1.47 $1.44 $1.14 $0.60 $1.28 $1.58
Tangible Book Value per Share
$1.16 $1.09 $0.99 $0.95 $0.87 $0.86 $0.82 $0.53 ($0.01) $0.74 $1.04
Total Capital
518 500 473 465 441 445 436 796 635 891 1,013
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 446 447 448 448
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 446 447 448 448
Net Debt
-307 -284 -258 -249 -229 -233 -278 -232 -194 -284 -419
Capital Expenditures (CapEx)
10 11 17 8.86 13 9.34 21 28 23 18 29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-74 -65 -71 -76 -69 -62 -126 -113 -335 -185 -220
Debt-free Net Working Capital (DFNWC)
234 220 187 173 160 170 152 566 306 546 648
Net Working Capital (NWC)
234 220 187 173 160 170 152 566 306 546 648
Net Nonoperating Expense (NNE)
6.34 5.09 11 4.26 22 -3.31 10 46 127 114 -0.10
Net Nonoperating Obligations (NNO)
-317 -294 -268 -253 -234 -238 -283 -237 -199 -291 -426
Total Depreciation and Amortization (D&A)
12 13 13 10 9.27 11 11 9.91 10 11 11
Debt-free, Cash-free Net Working Capital to Revenue
-33.42% -28.37% -30.17% -31.55% -28.04% -24.96% -47.96% -39.89% - -55.21% -58.10%
Debt-free Net Working Capital to Revenue
105.80% 96.12% 79.34% 71.39% 65.54% 68.06% 57.90% 200.23% - 162.82% 171.18%
Net Working Capital to Revenue
105.80% 96.12% 79.34% 71.39% 65.54% 68.06% 57.90% 200.23% - 162.82% 171.18%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.10) ($0.10) ($0.13) ($0.07) ($0.12) ($0.04) ($0.07) ($0.19) ($0.50) ($0.40) ($0.03)
Adjusted Weighted Average Basic Shares Outstanding
279.59M 288.27M 290.36M 293.34M 292.12M 300.27M 304.13M 309.25M 307.80M 345.52M 359.59M
Adjusted Diluted Earnings per Share
($0.10) ($0.10) ($0.13) ($0.07) ($0.12) ($0.04) ($0.07) ($0.19) ($0.50) ($0.40) ($0.03)
Adjusted Weighted Average Diluted Shares Outstanding
279.59M 288.27M 290.36M 293.34M 292.12M 300.27M 304.13M 309.25M 307.80M 345.52M 359.59M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
290.62M 290.77M 293.48M 296.71M 302.25M 303.43M 307.92M 313.66M 346.15M 356.40M 363.85M
Normalized Net Operating Profit after Tax (NOPAT)
-24 -24 -28 -16 -14 -16 -13 -13 -25 -24 -9.46
Normalized NOPAT Margin
-40.34% -40.04% -45.35% -25.83% -22.02% -24.05% -17.13% -15.80% - -25.94% -8.15%
Pre Tax Income Margin
-51.85% -47.73% -61.83% -32.74% -55.33% -17.66% -30.11% -71.87% - -146.43% -7.43%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -60.58 - -97.90 -9.46
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -12.59 - -16.89 -6.57
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -87.72 - -110.32 -29.71
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -39.73 - -29.31 -26.82
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Planet Labs PBC’s financial profile has improved meaningfully on growth and cash generation, although the company remains unprofitable. Revenue increased from $31.7 million in Q3 2022 to $116.1 million in Q2 2027. The latest quarter represented approximately 58% year-over-year growth from $73.4 million in Q2 2026 and 23% sequential growth from $94.2 million in Q1 2027.

Profitability trends also improved in Q2 2027. Gross profit rose to $65.6 million, producing a gross margin of approximately 56.6%, compared with 57.0% in Q1 2027 and 47.5% in Q2 2026. The operating loss narrowed to $13.5 million from $34.9 million in Q1. Net loss was $9.4 million, substantially better than the $138.9 million loss in Q1, although recent results have been affected by sizable non-operating expenses.

Planet Labs has also strengthened its liquidity. Cash, restricted cash and short-term investments totaled approximately $867.3 million at the end of Q2 2027, while long-term debt was $448.3 million. Operating cash flow was $52.9 million in the latest quarter, and capital expenditures of $29.1 million imply positive quarterly free cash flow of roughly $23.8 million. However, the balance sheet still reflects an accumulated retained-earnings deficit of $1.6 billion, and the company raised $123.7 million through common-equity issuance during Q2.

  • Strong revenue expansion: Quarterly revenue has more than tripled since Q3 2022, rising from $31.7 million to $116.1 million in Q2 2027.
  • Improving gross-margin profile: Q2 2027 gross margin was approximately 56.6%, well above the roughly 48% level reported in Q2 2026, suggesting improving economics as the business scales.
  • Narrower operating losses: The operating deficit improved to $13.5 million in Q2 2027 from $34.9 million in Q1 and $18.3 million in Q3 2026.
  • Positive operating cash flow: Operating cash flow increased to $52.9 million in Q2 2027 from $15.4 million in Q1 and $20.6 million in Q4 2026. After capital expenditures, the company still generated an estimated $23.8 million of free cash flow.
  • Large liquidity reserve: Cash, restricted cash and short-term investments totaled approximately $867.3 million, providing substantial financial flexibility relative to quarterly operating losses.
  • Deferred revenue remains significant: Current and noncurrent deferred revenue totaled approximately $298.6 million in Q2 2027. This can support future revenue recognition, but investors should monitor how quickly the balance converts into reported sales.
  • Non-operating results are volatile: Interest and investment income helped offset operating losses in Q2 2027, while large other expenses in Q1 and Q4 materially worsened reported net losses. This makes net income less representative of underlying operating performance.
  • The company remains unprofitable: Planet Labs reported a $9.4 million net loss and a $13.5 million operating loss in Q2 2027, while retained earnings remained negative at approximately $1.6 billion.
  • Equity dilution is a concern: Q2 2027 common-equity issuance provided $123.7 million of financing, and weighted-average basic shares increased to approximately 359.6 million from 304.1 million in Q2 2026.
  • Debt remains material: Long-term debt was approximately $448.3 million at the end of Q2 2027. Although the company held more cash and short-term investments than debt, continued losses could eventually increase reliance on external financing.
09/27/26 03:27 AM ETAI Generated. May Contain Errors.

Planet Labs PBC Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Planet Labs PBC's fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

Planet Labs PBC's net income appears to be on a downward trend, with a most recent value of -$246.86 million in 2026, falling from -$123.71 million in 2020. The previous period was -$123.20 million in 2025. Check out Planet Labs PBC's forecast to explore projected trends and price targets.

Planet Labs PBC's total operating income in 2026 was -$95.07 million, based on the following breakdown:
  • Total Gross Profit: $172.49 million
  • Total Operating Expenses: $267.56 million

Over the last 6 years, Planet Labs PBC's total revenue changed from $95.74 million in 2020 to $307.73 million in 2026, a change of 221.4%.

In the past 13 quarters, Planet Labs PBC's cash and equivalents has ranged from $101.55 million in Q3 2024 to $443.35 million in Q3 2026, and is currently $415.13 million as of their latest financial filing in Q2 2027.

Planet Labs PBC had total debt of $446.88 million at the end of 2026, compared with none in 2025, and none in 2020.

Over the last 6 years, Planet Labs PBC's book value per share changed from 0.00 in 2020 to 0.60 in 2026, a change of 100,016.7%.



Financial statements for NYSE:PL last updated on 9/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners